Search results
27 de ago. de 2023 · The ARREST trial is an investigator-led, prospective, parallel, multicentre, open-label, randomised superiority trial in which expedited transfer to a cardiac arrest centre was compared with current standard of care, comprising patient transfer to the geographically closest emergency department following resuscitated OHCA.
13 de nov. de 2020 · To our knowledge, the ARREST trial is the first randomised interventional trial to assess the effect of early ECMO-facilitated resuscitation compared with standard ACLS treatment for survival of patients with out-of-hospital refractory cardiac arrest.
20 de nov. de 2020 · ARREST. 20 November 2020 George Walker Emergency Medicine, Intensive Care Medicine 2 comments. Tweet. Advanced reperfusion strategies for patients with out-of-hospital cardiac arrest and refractory ventricular fibrillation (ARREST): a phase 2, single centre, open-label, randomised controlled trial. D Yannopoulos et al.
3 de jul. de 2021 · The ARREST trial was a phase 2, single-centre, open-label, adaptive, safety and efficacy randomised clinical trial comparing early extracorporeal membrane oxygenation (ECMO)-facilitated resuscitation to standard advanced cardiac life support (ACLS) in adults with out-of-hospital refractory ventricular fibrillation cardiac arrest.
5 de dic. de 2020 · Advanced reperfusion strategies for patients with out-of-hospital cardiac arrest and refractory ventricular fibrillation (ARREST): a phase 2, single centre, open-label, randomised controlled trial
25 de ene. de 2023 · The ARREST trial was terminated early because of superiority of the intervention: survival to discharge occurred in 6 of 14 patients (43%) in the group that received extracorporeal CPR as...
18 de mar. de 2019 · The most frequent cause of cardiac arrest is ischemic heart disease, and coronary artery disease has been reported in up to 70% of patients who have been resuscitated and are referred for immediate...
